Proglycem Suspension
Product Images NDC 0575-6200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Proglycem (NDC 0575-6200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Proglycem Suspension 017453 1

Chemical structure of diazoxide, the active ingredient in Proglycem 50 mg/mL oral suspension. The diagram shows the molecular arrangement including a benzene ring with chlorine substitution and a sulfonamide functional group.*

FDA Label Image

Proglycem Suspension 017453 2

Proglycem 50 mg per mL oral suspension label in 30 mL size. The product contains diazoxide as the active ingredient and is distributed by Teva Pharmaceuticals USA, Inc. The label includes usage instructions, storage conditions, and pharmacist notes, with the Teva logo prominently displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.